Hitchhiking cancer vaccine makes progress in the clinic
Elicio Therapeutics is testing a pancreatic cancer vaccine using technology first developed at MIT in clinical trials, with promising Phase 1 results.
Christopher Haqq Haipeng Liu Darrell Irvine Koch Institute Koch Institute For Integrative Cancer Research Elicio Therapeutics Inc
Source: mit.edu